Works matching AU Ansell, Stephen M.

Results: 210
    1
    2
    3

    Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study.

    Published in:
    Targeted Oncology, 2021, v. 16, n. 6, p. 761, doi. 10.1007/s11523-021-00849-8
    By:
    • Hawkes, Eliza A.;
    • Phillips, Tycel;
    • Budde, Lihua Elizabeth;
    • Santoro, Armando;
    • Saba, Nakhle S.;
    • Roncolato, Fernando;
    • Gregory, Gareth P.;
    • Verhoef, Gregor;
    • Offner, Fritz;
    • Quero, Cristina;
    • Radford, John;
    • Giannopoulos, Krzysztof;
    • Stevens, Don;
    • Thall, Aron;
    • Huang, Bo;
    • Laird, A. Douglas;
    • Sandner, Robin;
    • Ansell, Stephen M.
    Publication type:
    Article
    4
    5
    6

    Molecular Features of Diffuse Large B‐Cell Lymphoma Associated With Primary Treatment Resistance.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70006
    By:
    • Bock, Allison M.;
    • Wenzl, Kerstin;
    • Novak, Joseph P.;
    • Stokes, Matthew E.;
    • Hopper, Melissa A.;
    • Krull, Jordan E.;
    • Dropik, Abigail R.;
    • Sarangi, Vivek;
    • Ortiz, Maria;
    • Stong, Nicholas;
    • Huang, C. Chris;
    • Maurer, Matthew J.;
    • King, Rebecca L.;
    • Farooq, Umar;
    • Wang, Yucai;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Cerhan, James R.;
    • Gandhi, Anita K.
    Publication type:
    Article
    7

    Molecular classification and identification of an aggressive signature in low‐grade B‐cell lymphomas.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 4, p. 644, doi. 10.1002/hon.3187
    By:
    • Hopper, Melissa A.;
    • Wenzl, Kerstin;
    • Hartert, Keenan T.;
    • Krull, Jordan E.;
    • Dropik, Abigail R.;
    • Novak, Joseph P.;
    • Manske, Michelle K.;
    • Serres, MaKayla R.;
    • Sarangi, Vivekananda;
    • Larson, Melissa C.;
    • Maurer, Matthew J.;
    • Yang, Zhi‐Zhang;
    • Paludo, Jonas;
    • McPhail, Ellen D.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Rimsza, Lisa M.;
    • Ansell, Stephen M.;
    • Cerhan, James R.;
    • Jevremovic, Dragan
    Publication type:
    Article
    8
    9

    Outcomes in primary cutaneous diffuse large B‐cell lymphoma, leg type.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 5, p. 658, doi. 10.1002/hon.2919
    By:
    • Kraft, Robert M.;
    • Ansell, Stephen M.;
    • Villasboas, Jose C.;
    • Bennani, N. Nora;
    • Wang, Yucai;
    • Habermann, Thomas M.;
    • Thanarajasingam, Gita;
    • Lester, Scott C.;
    • Macon, William;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Micallef, Ivana N.;
    • Witzig, Thomas E.;
    • Thompson, Carrie A.;
    • Johnston, Patrick B.;
    • Nowakowski, Grzegorz S.;
    • Lin, Yi;
    • Paludo, Jonas
    Publication type:
    Article
    10

    Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 2, p. 185, doi. 10.1002/hon.2838
    By:
    • Hutchings, Martin;
    • Radford, John;
    • Ansell, Stephen M.;
    • Illés, Árpád;
    • Sureda, Anna;
    • Connors, Joseph M.;
    • Sýkorová, Alice;
    • Shibayama, Hirohiko;
    • Abramson, Jeremy S.;
    • Chua, Neil S.;
    • Friedberg, Jonathan W.;
    • Kořen, Jan;
    • LaCasce, Ann Steward;
    • Molina, Lysiane;
    • Engley, Gerald;
    • Fenton, Keenan;
    • Jolin, Hina;
    • Liu, Rachael;
    • Gautam, Ashish;
    • Gallamini, Andrea
    Publication type:
    Article
    11

    FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.

    Published in:
    2017
    By:
    • Ghesquières, Hervé;
    • Larrabee, Beth R.;
    • Haioun, Corinne;
    • Link, Brian K.;
    • Verney, Aurélie;
    • Slager, Susan L.;
    • Ketterer, Nicolas;
    • Ansell, Stephen M.;
    • Delarue, Richard;
    • Maurer, Matthew J.;
    • Fitoussi, Olivier;
    • Habermann, Thomas M.;
    • Peyrade, Fréderic;
    • Dogan, Ahmet;
    • Molina, Thierry J.;
    • Novak, Anne J.;
    • Tilly, Hervé;
    • Cerhan, James R.;
    • Salles, Gilles;
    • Ghesquières, Hervé
    Publication type:
    journal article
    12

    Immunotherapy in lymphoma.

    Published in:
    2017
    By:
    • Ansell, Stephen M.;
    • Caligaris‐Cappio, Federico;
    • Maloney, David G.;
    • Caligaris-Cappio, Federico
    Publication type:
    journal article
    13
    14

    The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma.

    Published in:
    Leukemia & Lymphoma, 2005, v. 46, n. 9, p. 1287, doi. 10.1080/10428190500126380
    By:
    • Yinlee Yoong;
    • Porrata, Luis F.;
    • Inwards, David J.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N. M.;
    • Litzow, Mark R.;
    • Gertz, Morie A.;
    • Lacy, Martha Q.;
    • Dispenzieri, Angela;
    • Gastineau, Dennis A.;
    • Tefferi, Ayalew;
    • Elliott, Michelle;
    • Snow, Denis S.;
    • Hogan, Willian J.;
    • Markovic, Svetomir N.
    Publication type:
    Article
    15
    16
    17
    18
    19

    Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer.

    Published in:
    Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01848-z
    By:
    • Leon-Ferre, Roberto A.;
    • Whitaker, Kaitlyn R.;
    • Suman, Vera J.;
    • Hoskin, Tanya;
    • Giridhar, Karthik V.;
    • Moore, Raymond M.;
    • Al-Jarrad, Ahmad;
    • McLaughlin, Sarah A.;
    • Northfelt, Donald W.;
    • Hunt, Katie N.;
    • Conners, Amy Lynn;
    • Moyer, Ann;
    • Carter, Jodi M.;
    • Kalari, Krishna;
    • Weinshilboum, Richard;
    • Wang, Liewei;
    • Ingle, James N.;
    • Knutson, Keith L.;
    • Ansell, Stephen M.;
    • Boughey, Judy C.
    Publication type:
    Article
    20
    21
    22
    23

    Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II–IV peripheral T‐cell lymphoma.

    Published in:
    British Journal of Haematology, 2023, v. 202, n. 3, p. 525, doi. 10.1111/bjh.18885
    By:
    • Stuver, Robert;
    • Horwitz, Steven M.;
    • Advani, Ranjana H.;
    • Vose, Julie M.;
    • Lee, Hun Ju;
    • Mehta‐Shah, Neha;
    • Zain, Jasmine M.;
    • Haverkos, Bradley;
    • Lechowicz, Mary Jo;
    • Moskowitz, Alison J.;
    • Pham, Luu Q.;
    • Leyden, Elizabeth;
    • Ansell, Stephen M.;
    • Lunning, Matthew A.
    Publication type:
    Article
    24

    Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.

    Published in:
    British Journal of Haematology, 2021, v. 195, n. 2, p. 210, doi. 10.1111/bjh.17691
    By:
    • Zanwar, Saurabh;
    • Abeykoon, Jithma P.;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • Colby, Colin;
    • Larson, Dirk;
    • Paludo, Jonas;
    • He, Rong;
    • Warsame, Rahma;
    • Greipp, Patricia T.;
    • King, Rebecca L.;
    • Thompson, Carrie A.;
    • Witzig, Thomas E.;
    • Lacy, Martha Q.;
    • Gonsalves, Wilson;
    • Nowakowski, Grzegorz S.;
    • Dingli, David;
    • Go, Ronald S.;
    • Habermann, Thomas M.;
    • Vincent Rajkumar, S.
    Publication type:
    Article
    25

    Long‐term outcome of immunologic autograft engineering.

    Published in:
    EJHaem, 2022, v. 3, n. 2, p. 488, doi. 10.1002/jha2.404
    By:
    • Porrata, Luis F.;
    • Inwards, David J.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Villasboas, Jose C.;
    • Paludo, Jonas;
    • Markovic, Svetomir N.
    Publication type:
    Article
    26
    27
    28
    29

    Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e300, doi. 10.1016/j.clml.2021.10.018
    By:
    • Bennani, N. Nora;
    • Tun, Aung M.;
    • Carson, Kenneth R;
    • Geiger, Jessica L;
    • Maeda, Lauren S;
    • Savage, Kerry J;
    • Rose, Jim;
    • Pinter-Brown, Lauren;
    • Lunning, Matthew A;
    • Abramson, Jeremy S;
    • Bartlett, Nancy L;
    • Vose, Julie M;
    • Evens, Andrew M;
    • Smith, Sonali M;
    • Horwitz, Steven M;
    • Ansell, Stephen M.;
    • Advani, Ranjana H
    Publication type:
    Article
    30

    Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 4, p. e250, doi. 10.1016/j.clml.2021.10.004
    By:
    • Bennani, N. Nora;
    • Tun, Aung M.;
    • Carson, Kenneth R.;
    • Geiger, Jessica L.;
    • Maeda, Lauren S.;
    • Savage, Kerry J.;
    • Rose, Jim;
    • Pinter-Brown, Lauren;
    • Lunning, Matthew A.;
    • Abramson, Jeremy S.;
    • Bartlett, Nancy L.;
    • Vose, Julie M.;
    • Evens, Andrew M.;
    • Smith, Sonali M.;
    • Horwitz, Steven M.;
    • Ansell, Stephen M.;
    • Advani, Ranjana H.
    Publication type:
    Article
    31

    Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. e89, doi. 10.1016/j.clml.2021.08.011
    By:
    • Iqbal, Madiha;
    • Castano, Yennifer Gil;
    • Paludo, Jonas;
    • Rosenthal, Allison;
    • Zhuo Li;
    • Beltran, Manuel;
    • Moustafa, Muhamad Alhaj;
    • Inwards, David;
    • Porrata, Luis;
    • Micallef, Ivana;
    • Bisneto, Jose C. Villasboas;
    • Johnston, Patrick;
    • Ansell, Stephen M.;
    • Reeder, Craig;
    • Murthy, Hemant;
    • Roy, Vivek;
    • Foran, James;
    • Tun, Han W.;
    • Kharfan-Dabaja, Mohamed A.;
    • Ayala, Ernesto
    Publication type:
    Article
    32
    33

    HL-147: Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S371, doi. 10.1016/S2152-2650(21)01849-8
    By:
    • Ramchandren, Radhakrishnan;
    • Dfugosz-Danecka, Monika;
    • Connors, Joseph M.;
    • Radford, John;
    • Illés, Árpád;
    • Picardi, Marco;
    • Lech-Maranda, Ewa;
    • Feldman, Tatyana;
    • Smolewski, Piotr;
    • Savage, Kerry J.;
    • Bartlett, Nancy L.;
    • Walewski, Jan;
    • Zinzani, Pier Luigi;
    • Hutchings, Martin;
    • Munoz, Javier;
    • Won Seog Kim;
    • Advani, Ranjana;
    • Ansell, Stephen M.;
    • Gallamini, Andrea;
    • Alekseev, Sergey
    Publication type:
    Article
    34
    35

    Poster: HL-147: Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S236, doi. 10.1016/S2152-2650(21)01485-3
    By:
    • Ramchandren, Radhakrishnan;
    • Długosz-Danecka, Monika;
    • Connors, Joseph M.;
    • Radford, John;
    • Illés, Árpád;
    • Picardi, Marco;
    • Lech-Maranda, Ewa;
    • Feldman, Tatyana;
    • Smolewski, Piotr;
    • Savage, Kerry J.;
    • Bartlett, Nancy L.;
    • Walewski, Jan;
    • Zinzani, Pier Luigi;
    • Hutchings, Martin;
    • Munoz, Javier;
    • Won Seog Kim;
    • Advani, Ranjana;
    • Ansell, Stephen M.;
    • Gallamini, Andrea;
    • Alekseev, Sergey
    Publication type:
    Article
    36
    37

    A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.

    Published in:
    2018
    By:
    • Padrnos, Leslie;
    • Ernst, Brenda;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Toro, Angela;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Nowakowski, Grzegorz S.;
    • Colgan, Joseph;
    • Porrata, Luis;
    • Ansell, Stephen M.;
    • Witzig, Thomas E.;
    • Reeder, Craig
    Publication type:
    journal article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Baseline echocardiographic variables as predictors of hemodynamically significant cytokine release syndrome in adults treated with CD19 CAR T-cell therapy for hematological malignancies.

    Published in:
    Cardio-Oncology, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40959-024-00290-6
    By:
    • Daryanani, Andres E.;
    • Abbasi, Muhannad A.;
    • Gomez Ardila, Maria F.;
    • Tellez-Garcia, Eduardo;
    • Garzon-Dangond, Juan M.;
    • Lin, Yi;
    • Paludo, Jonas;
    • Herrmann, Joerg;
    • Ansell, Stephen M.;
    • Rosenthal, Allison C.;
    • Villarraga, Hector R.
    Publication type:
    Article
    49
    50